Future Microbiology · 2018 · 69 citations · 14 references
Veterinary MedicineInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologySepsisAntibacterial TherapyAntibiotic ResistanceAntimicrobial Susceptibility TestingAntimicrobial TherapyBacterial InfectionsMultidrug ResistanceAssayMultidrug-resistant PathogensPneumococcal DiseaseSynergistic Impacts
AIM: To test the synergistic effect of Cpl-711 endolysin and antibiotics for antipneumococcal activity. MATERIALS & METHODS: A combination of Cpl-711 and different antibiotics (amoxicillin, cefotaxime, levofloxacin and vancomycin) was tested in a checkerboard assay against several multidrug-resistant Streptococcus pneumoniae strains. Mouse and zebrafish models of pneumococcal sepsis were used to confirm the in vitro data. RESULTS: The activity of Cpl-711 combined with amoxicillin or cefotaxime was synergistic in the bactericidal effect against a serotype 23F multiresistant clinical isolate of S. pneumoniae. Synergy between Cpl-711 and cefotaxime was validated using both mouse and zebrafish models. CONCLUSION: Combination of Cpl-711 and cefotaxime may help in the treatment of diseases caused by multiresistant pneumococcal strains.
14
Roberto Díez‐Martínez, Héctor D. de Paz, Esther García‐Fernández et al. · Journal of Antimicrobial Chemotherapy · 2015 · 123 citations · Full text
Svetolik Djurkovic, Jutta M. Loeffler, Vincent A. Fischetti · Antimicrobial Agents and Chemotherapy · 2005 · 108 citations · Full text